Last Updated : August 15, 2019
Details
Generic Name:
vilazodone
Project Status:
Not filed
Therapeutic Area:
Depression, Major depressive disorder
Manufacturer:
Allergan Inc.
Brand Name:
Viibryd
Project Line:
Reimbursement Review
Project Number:
NS0006-000
Submission Type:
Non Submission
Fee Schedule:
N/A
Indications:
Depression, Major depressive disorder
Review Status:
Not Filed
Recommendation Type:
Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission.
Last Updated : August 15, 2019